The hourlong program "Why Can't We Cure Cancer? A National Conversation" comes as a follow-up to NewsNation's November ...

ImmunityBio, Inc. (Nasdaq: IBRX), a commercial-stage biotechnology company pioneering next-generation immunotherapies, today ...

Add Yahoo as a preferred source to see more of our stories on Google. Patrick Soon-Shiong attends a Urban Economic Forum co-hosted by White House Business Council and U.S. Small Business ...

The owner of the troubled Los Angeles Times, billionaire Patrick Soon-Shiong, is still intent on taking the once-storied newspaper public, but he's starting with a trial balloon. On Oct. 10, ...

(Bloomberg) -- Two Republican lawmakers were invited to attend a Food and Drug Administration meeting about the potential expanded approval of a drug backed by billionaire Patrick Soon-Shiong, but the ...

Billionaire physician and medical entrepreneur Patrick Soon-Shiong, MD, is facing criticism for reportedly boosting sales of his GPS Cancer genetic tests by citing positive experiences from three ...

MEGYN KELLY SHOW: Megyn Kelly is joined by Dr. Patrick Soon-Shiong, CEO of Los Angeles Times Media Group, to talk about why he stopped his paper from publishing their Kamala Harris endorsement, his ...

Dr. Patrick Soon-Shiong announced that NantWorks is the name of the company that he has been building through a series of acquisitions over the past few years. Following the sales of two companies ...

Patrick Soon-Shiong, MD, the billionaire founder and CEO of NantHealth, has purchased the Los Angeles Times from Tronc, according to The Washington Post. Under the $500 million deal, Dr. Soon-Shiong, ...

Patrick Soon-Shiong attends a Urban Economic Forum co-hosted by White House Business Council and U.S. Small Business Administration. (Credit: Kevork Djansezian/Getty Images) Patrick Soon-Shiong denies ...